MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-08-0002682
Zoomex Therapeutics Private Limited
Zoomex Therapeutics Private Limited - pharma in Kozhikode, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹12.03 Lakh
▼ 26% YoY
Net loss · FY 2022
₹4,616
Net margin -0.4%
EBITDA · FY 2022
₹2.45 Lakh
EBITDA margin 20.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5.6 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Zoomex Therapeutics Private Limited
Data last updated:
Zoomex Therapeutics Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2010PTC025969. Its GSTIN is 32AAACZ5512H1ZL (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.6 Lakh. It is led by directors Paladankandy Nidheesh and Kattoor Athira Puthan Veedu.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Kozhikode, Kerala.
As per the financials filed for FY 2022, the company reported a revenue of ₹12.03 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹4,616 (net margin -0.4%) and EBITDA of ₹2.45 Lakh (EBITDA margin 20.3%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 35% over five years.
As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Zoomex Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-08-0002682). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233KL2010PTC025969
Registration Number 025969
Incorporation Date 06 May 2010
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-08-0002682
Recognitions & Rankings of Zoomex Therapeutics
Contact details
Zoomex Therapeutics Private Limited's registered office is in Kozhikode, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRoom No. 25/1150, Kairali Complex Thondayad, Kozhikode, Kerala, India – 673016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zoomex Therapeutics Private Limited, buy the company report.
Comprehensive company report
Zoomex Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zoomex Therapeutics is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zoomex Therapeutics Private Limited, buy the company report.
Financials of Zoomex Therapeutics Private Limited
FY 2022 filings availableZoomex Therapeutics Private Limited reported revenue of ₹12.03 Lakh (down 26% YoY) for FY 2022.
Revenue · FY 2022
₹12.03 Lakh ▼ 26%
Net loss · FY 2022
₹4,616 margin -0.4%
EBITDA · FY 2022
₹2.45 Lakh margin 20.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 33%
5 years · compounded
▼ 35%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 30%
5 years · compounded
▼ 30%
Revenue has declined at a compounded annual rate (CAGR) of 35% over five years, including a 26% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹12.03 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,616 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.3% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zoomex Therapeutics Private Limited, buy the company report.
Board of directors of Zoomex Therapeutics Private Limited
Zoomex Therapeutics has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paladankandy Nidheesh Also directs: Le Aayush Laboratory LLP | Director | 25 Feb 2014 | 12 Years 8 Months | Current |
| Kattoor Athira Puthan Veedu | Director | 23 Sep 2023 | 3 Years 1 Months | Current |
Shareholding
The shareholding of Zoomex Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zoomex Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹60 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jun 2014 | 10506538 | State Bank of Travancore | ₹60 Lakh | Open |
To see the full charge records of Zoomex Therapeutics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Zoomex Therapeutics Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Invent Bio-Med Pvt. Ltd. | Disposed |
| District court, Ernakulam, Kerala | Criminal case | Filed against the company | Pending |
To see the full case history of Zoomex Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zoomex Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zoomex Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACZ5512H1ZL | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zoomex Therapeutics Private Limited, buy the company report.
Recent activity
Zoomex Therapeutics Private Limited has 11 board changes on record since 2014: 2 appointments and 9 cessations. The latest: Manoj Unnikrishnan ceased to be Director on 27 Sep 2023.
Ceased
Manoj Unnikrishnan ceased to be Director.
Appointed
Kattoor Athira Puthan Veedu was appointed as Director.
AGM
Zoomex Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Zoomex Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ernakulam.
Ceased
Rony Oommen Varghese ceased to be Managing Director.
Charges
A charge with State Bank Of Travancore of Rs. 60.00 Lakh registered on 10 Jun 2014 with Charge ID 10506538 was modified on 11 Feb 2016.
Ceased
Kozhisserikalam Dhanya ceased to be Additional Director.
Ceased
Sarath Unnikrishnan ceased to be Additional Director.
Ceased
Jayan Kanakkizhi Kandari ceased to be Managing Director.
Ceased
Kanakkazhi Kandari Rajesh ceased to be Additional Director.
Ceased
Muralidhara Kamath Venkiteswara Kamath ceased to be Director.
Ceased
Somasundaresan Nair Raman Pillai ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Zoomex Therapeutics is an active private limited company based in Kozhikode, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 May 2010 (16+ years old) and is registered under CIN U24233KL2010PTC025969.
Zoomex Therapeutics has 2 current directors:
- Paladankandy Nidheesh - Director
- Kattoor Athira Puthan Veedu - Director
The latest financial statements of Zoomex Therapeutics on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Zoomex Therapeutics is 32AAACZ5512H1ZL, registered in Kerala.
The CIN (Corporate Identification Number) of Zoomex Therapeutics is U24233KL2010PTC025969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoomex Therapeutics has 2 court cases on record: 2 filed against it. 1 is pending.
Zoomex Therapeutics was incorporated on 06 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ernakulam.
Manoj Unnikrishnan ceased to be Director on 27 Sep 2023. Kattoor Athira Puthan Veedu was appointed as Director on 23 Sep 2023. Rony Oommen Varghese ceased to be Managing Director on 23 Nov 2017. Zoomex Therapeutics has 11 board changes on record in total.
Yes, Zoomex Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-08-0002682).
The registered office of Zoomex Therapeutics is at Room No. 251150, Kairali Complex Thondayad, Kozhikode, Kerala, India – 673016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages